VDRM (ViaDerma) ROE % Adjusted to Book Value: 368.00% (As of Jun. 2012)


What is ViaDerma ROE % Adjusted to Book Value?

ViaDerma VDRM +33.33% ROE % Adjusted to Book Value is 368.00% as of Jun. 2012.

ViaDerma's ROE % for the quarter that ended in Jun. 2012 was 11.04%. ViaDerma's PB Ratio for the quarter that ended in Jun. 2012 was 0.03. ViaDerma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2012 was 368.00%.

ViaDerma ROE % Adjusted to Book Value Related Terms

ViaDerma ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for ViaDerma's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViaDerma ROE % Adjusted to Book Value Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
ROE % Adjusted to Book Value
0.00 762.10 11.51 65.85 213.00

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 458.67 174.33 161.25 237.00 368.00

VDRM vs AOLS, RDGL, PCYN: ROE % Adjusted to Book Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, ViaDerma's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ViaDerma ROE % Adjusted to Book Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, ViaDerma's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where ViaDerma's ROE % Adjusted to Book Value falls into.


ViaDerma ROE % Adjusted to Book Value Calculation

ViaDerma's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2011 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=8.52% / 0.04
=213.00%

ViaDerma's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2012 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=11.04% / 0.03
=368.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 368.00% mean?
ViaDerma (VDRM) has a ROE % Adjusted to Book Value of 368.00% as of Jun. 2012. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on ViaDerma and its competitors.
Is ViaDerma's ROE % Adjusted to Book Value too high?
ViaDerma's current ROE % Adjusted to Book Value is 368.00%.
How does ViaDerma's ROE % Adjusted to Book Value compare to AOLS and RDGL?
ViaDerma's ROE % Adjusted to Book Value of 368.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Drug Manufacturers company?
A good ROE % Adjusted to Book Value depends on the Drug Manufacturers industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on ViaDerma and its competitors. ViaDerma's current ROE % Adjusted to Book Value is 368.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViaDerma stock overvalued right now?
ViaDerma (VDRM) has a current ROE % Adjusted to Book Value of 368.00%. The current ROE % Adjusted to Book Value is 368.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For ViaDerma (VDRM), the current ROE % Adjusted to Book Value is 368.00% as of Jun. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ViaDerma Business Description

Address 4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.